Atlas Trials

Durability and Tolerability of Infliximab in Pediatric Inflammatory Bowel Disease Patients: A 10 Year Single Center Experience

Clinical trial NCT01490528 · UNKNOWN

Trial details

NCT number
NCT01490528
Sponsor
Cedars-Sinai Medical Center
Status
UNKNOWN
Study type
OBSERVATIONAL
Pediatric Inflammatory Bowel Disease
Start date
2012-01-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.